IP Library Granted Patent US 12,415,004
Granted Patent B2
US 12,415,004 · App. 18/219,948 · Granted Sep 16, 2025

Light disinfecting apparatus and methods

Inventor: Brett M. Zaborsky (San Diego, CA)
Assignee: Inikoa Medical, Ic.
A61L2/0023A61B1/07A61L2/0047A61L2/08A61L2/084A61L2/10A61M25/0026A61M39/16A61M39/28G01M11/31G02B6/02G02B6/102A61L2202/11A61L2202/14A61L2202/16A61L2202/24A61M2025/0019A61M2025/004A61N5/0624
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,415,004
App. No.
18/219,948
Granted
Sep 16, 2025
Kind
B2
Abstract

An assembly for redirecting light emitted by an end-emitting optical fiber into an inner lumen of a body is provided. According to one implementation, the body includes one or more surfaces disposed on or in the body onto which the light is configured to impinge when the end emitting optical fiber is activated, the one or more surfaces being configured to alter the trajectory of the light so that the light is directed to impinge on a light reflector of a cap removably attached to the body, the light reflector of the cap being configured to redirect the light distally into the inner lumen of the body.

Claims (27)

1. A central venous catheter comprising:

a main shaft having a proximal end portion and a distal end portion, the distal end portion configured for placement inside a patient, the main shaft having a working lumen;

a first infusion shaft having a proximal end portion and a distal end portion, the first infusion shaft having a working lumen;

a first optical fiber having a length and being configured to emit bacterial disinfecting light; and

a hub having a proximal end and a distal end, the distal end portion of the first infusion shaft being coupled to the main shaft by a first conduit located inside the hub, the first conduit fluidly connecting the working lumen of the first infusion shaft with the working lumen of the main shaft, the hub having a first channel that houses at least a portion of the length of the first optical fiber, the first channel being located outside the conduit and not forming a part of the main shaft, nor a part of the infusion shaft.

2. The central venous catheter according to claim 1 , wherein the first optical fiber is an end emitting fiber that is configured to end emit bacterial disinfecting light to disinfect at least a portion of the hub.

3. The central venous catheter according to claim 2 , wherein the first optical fiber is configured to end emit bacterial disinfecting light to disinfect at least a portion of the first conduit.

4. The central venous catheter according to claim 3 , wherein the first conduit comprises a tubular body that is transparent or translucent to the bacterial disinfecting light.

5. The central venous catheter according to claim 1 , wherein the first optical fiber is an end emitting fiber that is configured to end emit bacterial disinfecting light to disinfect at least a portion of the first conduit.

6. The central venous catheter according to claim 5 , wherein the first conduit comprises a tubular body that is transparent or translucent to the bacterial disinfecting light.

7. The central venous catheter according to claim 1 , wherein the first conduit comprises a tubular body that is transparent or translucent to the bacterial disinfecting light.

8. The central venous catheter according to claim 1 , wherein the first channel includes a first segment at a first elevation and a second segment at a second elevation different than the first elevation.

9. The central venous catheter according to claim 1 , further comprising a second optical fiber having a length and being configured to emit bacterial disinfecting light; and

a second channel located inside the hub that houses at least a portion of the length of the second optical fiber.

10. The central venous catheter according to claim 9 , wherein each of the first optical fiber and the second optical fiber is an end emitting fiber that is configured to end emit bacterial disinfecting light.

11. The central venous catheter according to claim 9 , wherein each of the first optical fiber and the second optical fiber is an end emitting fiber that is each configured to end emit bacterial disinfecting light to disinfect at least a portion of the hub.

12. The central venous catheter according to claim 9 , wherein the hub comprises a raised platform that has a side wall, at least a portion of the length of the second optical fiber being routed inside the hub at least partially around the raised platform.

13. The central venous catheter according to claim 12 , wherein at least a portion of the length of each of the first optical fiber and the second optical fiber is routed inside the hub at least partially around the raised platform.

14. The central venous catheter according to claim 9 further comprising:

a second infusion shaft having a proximal end portion and a distal end portion, the second infusion shaft having a working lumen;

the distal end portion of the second infusion shaft being coupled to the main shaft by a second conduit located inside the hub, the second conduit fluidly connecting the working lumen of the second infusion shaft with the working lumen of the main shaft, the second channel being located outside the second conduit and not forming a part of the main shaft, nor a part of the infusion shaft.

15. The central venous catheter according to claim 14 , wherein each of the first optical fiber and the second optical fiber is an end emitting fiber that is each configured to end emit bacterial disinfecting light to disinfect at least a portion of the hub.

16. The central venous catheter according to claim 14 , wherein the first optical fiber is an end emitting fiber that is configured to end emit bacterial disinfecting light to disinfect at least a portion of the first conduit, and the second optical fiber is an end emitting fiber that is configured to end emit bacterial disinfecting light to disinfect at least a portion of the second conduit.

17. The central venous catheter according to claim 16 , wherein each of the first conduit and the second conduit comprises a tubular body that is transparent or translucent to the bacterial disinfecting light.

18. The central venous catheter according to claim 9 , wherein each of the first optical fiber and the second optical fiber is an end emitting fiber that is configured to end emit bacterial emitting light.

19. The central venous catheter according to claim 1 , wherein the hub comprises a raised platform that has a side wall that at least partially defines the first channel.

20. The central venous catheter according to claim 19 , wherein at least a portion of the length of the first optical fiber is routed inside the hub at least partially around the raised platform.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2024
From: INIKOA MEDICAL, INC.
To: ZABORSKY, BRETT
Reel/Frame 066222/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2023
From: ZABORSKY, BRETT M.
To: INIKOA MEDICAL, INC.
Reel/Frame 065245/0434 →
Continuity (6)
Continuation 17015831 · Sep 9, 2020
Continuation 16863419 · Apr 30, 2020
Continuation 15876796 · Jan 22, 2018
Continuation In Part 15631674 · Jun 23, 2017
Continuation 15629494 · Jun 21, 2017
Related Publication 20240000981A1 · Jan 4, 2024
References Cited (40)
US 4412834A · Kulin · 1983 [cited by applicant]
US 5260020A · Wilk et al. · 1993 [cited by applicant]
US 5637877A · Sinofsky · 1997 [cited by applicant]
US 5695482A · Kaldany · 1997 [cited by applicant]
US 6461569B1 · Boudreaux · 2002 [cited by applicant]
US 6524529B1 · Horton, III · 2003 [cited by applicant]
US 6564087B1 · Pitris et al. · 2003 [cited by applicant]
US 7274844B2 · Walt et al. · 2007 [cited by applicant]
US 7686839B2 · Parker · 2010 [cited by applicant]
US 8197087B2 · Sobue et al. · 2012 [cited by applicant]
US 8431910B1 · Perry · 2013 [cited by applicant]
US 8556950B2 · Rioux et al. · 2013 [cited by applicant]
US 8574490B2 · Haytman et al. · 2013 [cited by applicant]
US 8632576B2 · Quisenberry · 2014 [cited by applicant]
US 8702640B2 · Dacey, Jr. et al. · 2014 [cited by applicant]
US 8706211B2 · Dacey, Jr. et al. · 2014 [cited by applicant]
US 8953914B2 · Genier · 2015 [cited by applicant]
US 9259513B2 · Bedwell et al. · 2016 [cited by applicant]
US 9278148B2 · Fewkes et al. · 2016 [cited by applicant]
US 9295742B2 · Rasooly et al. · 2016 [cited by applicant]
US 20020025097A1 · Cooper et al. · 2002 [cited by applicant]
US 20020037133A1 · Unsworth · 2002 [cited by applicant]
US 20030017073A1 · Eckhardt et al. · 2003 [cited by applicant]
US 20050175658A1 · Dimauro et al. · 2005 [cited by applicant]
US 20050279354A1 · Deutsch et al. · 2005 [cited by applicant]
US 20060140562A1 · Joseph et al. · 2006 [cited by applicant]
US 20060206997A1 · Chiang et al. · 2006 [cited by applicant]
US 20110291995A1 · Shr et al. · 2011 [cited by applicant]
US 20120321509A1 · Bak · 2012 [cited by applicant]
US 20130035629A1 · Soltz et al. · 2013 [cited by applicant]
US 20130115131A1 · Hegg et al. · 2013 [cited by applicant]
US 20130267888A1 · Rhodes et al. · 2013 [cited by applicant]
US 20150043875A1 · Bookbinder et al. · 2015 [cited by applicant]
US 20150126976A1 · Tang et al. · 2015 [cited by applicant]
US 20150148734A1 · Fewkew et al. · 2015 [cited by applicant]
US 20150231287A1 · Lin et al. · 2015 [cited by applicant]
US 20150335773A1 · Bauco · 2015 [cited by applicant]
US 20160001038A1 · Romo et al. · 2016 [cited by applicant]
WO 2014159874A1 · 2014 [cited by applicant]
International Search Report and Written Opinion in corresponding International Application No. PCT/US18/38199, mailed Jul. 27, 2018 (6 pages). [cited by applicant]